Perspective Therapeutics Stock Forecast

Sell candidate since Oct 17, 2025 Loss -50.56%

The Perspective Therapeutics, Inc. stock price gained 6.73% on the last trading day (Monday, 17th Nov 2025), rising from $2.08 to $2.22. During the last trading day the stock fluctuated 11.57% from a day low at $2.08 to a day high of $2.32. The price has fallen in 5 of the last 10 days and is down by -14.62% for this period. Volume fell on the last day by -2 million shares and in total, 3 million shares were bought and sold for approximately $7.00 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.01 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -18.77% during the next 3 months and, with a 90% probability hold a price between $1.63 and $3.74 at the end of this 3-month period.

CATX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, November 13, 2025, and so far it has risen 8.58%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Perspective Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.18. On a fall, the stock will find some support from the short-term average at $2.16. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Perspective Therapeutics, Inc. stock

Perspective Therapeutics, Inc. finds support from accumulated volume at $2.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 11.57%. For the last week, the stock has had daily average volatility of 9.77%.

Perspective Therapeutics, Inc. is oversold on RSI14 (24). Some stock may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CATX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Perspective Therapeutics, Inc. to open at $2.20, and during the day (based on 14 day Average True Range), to move between $2.09 and $2.35, which gives a possible trading interval of +/-$0.253 (+/-12.10%) up or down from last closing price. If Perspective Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 12.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.23 (0.45%) than the support at $2.19 (1.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Perspective Therapeutics, Inc. stock A Buy?

Perspective Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.429 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.20 ( 0.751%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk